• SENSEX 80,918.78
    -266.80 (--0.33%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Bacil Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 3688.0
  • ISIN : INE711D01018
37.58 2 (4.97%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    34.01

  • Today’s High

    37.58

  • Open

    34.01

  • Perv Close

    35.80

  • 52W Low

    14.85

  • 52W High

    62.56

Key Indicators

  • P/E(TTM)

    134.21

  • Mar.Cap (₹Cr.)

    53.94

  • Div & Yield %

    0.00

  • Book Value(₹)

    17.98

  • Debt-Equity Ratio

    4.97

  • AGM Date

    28-Jul-2025

  • EPS

    0.28

  • P/E Ratio

    134.21

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    53.94

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    14.35

  • BV (₹)

    18.00

  • Sales( ₹ in Cr.)

    0.00

  • NP (in Cr.)

    0.40

  • NP Var(%)

    353.0

  • Div%

    0.0

  • CPS (₹)

    0.30

  • EPS (₹)

    0.30

  • Traded Value (₹ in Lakhs)

    53.94

  • 52 Week High

    62.56

  • 52 Week Low

    14.85

  • Price BSE

    38.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    53.94

  • P/C Ratio

    134.70

  • P/E Ratio

    135.00

  • Price Vs.BV

    0.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 0.00 0.00 0.00 0.00 0.00 0.00
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.13 0.11 0.06 0.07 0.14 0.09
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 0.13 0.11 0.06 0.07 0.14 0.09
EXPENDITURE :            
Raw Materials 0.00 0.00 0.00 0.00 0.00 0.00
Power and Fuel Cost 0.00 0.00 0.00 0.00 0.00 0.01
Employee Cost 0.10 0.09 0.06 0.05 0.09 0.08
Other Manufacturing Expenses 0.00 0.00 0.00 0.00 0.00 0.01
Selling and Administration Expenses 0.08 0.08 0.09 0.08 0.08 0.16
Miscellaneous Expenses 0.00 0.05 3.76 0.17 0.26 0.18
Employee Benefit Expenses 0.10 0.09 0.06 0.05 0.09 0.08
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 0.19 0.21 3.91 0.30 0.44 0.43
Operating Profit -0.06 -0.10 -3.86 -0.23 -0.30 -0.33
Interest 0.00 0.00 0.00 0.00 0.01 0.00
Gross Profit -0.06 -0.10 -3.86 -0.23 -0.31 -0.33
Depreciation 0.00 0.00 0.00 0.00 0.01 0.01
Profit Before Tax -0.06 -0.10 -3.86 -0.23 -0.32 -0.34
Current Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit -0.06 -0.10 -3.86 -0.24 -0.32 -0.34
Extraordinary Items 0.10 0.05 -3.76 -0.14 -0.26 -0.16
Adjusted Net Profit -0.16 -0.15 -0.10 -0.10 -0.06 -0.18
Adjustment below Net Profit 0.17 -0.02 3.69 0.24 -0.21 0.02
P & L Balance brought forward -5.43 -5.30 -5.14 -5.14 -4.62 -4.29
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -5.31 -5.43 -5.30 -5.14 -5.14 -4.62
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -0.09 -0.16 -5.91 -0.37 -0.48 0.00
Earnings Per Share(Adj)-Unit Curr -0.09 -0.16 -5.91 -0.37 -0.48 -
Book Value 1.86 1.68 1.88 2.13 2.12 2.93
Book Value(Adj)-Unit Curr 1.86 1.68 1.88 2.13 2.12 -

Shareholding Pattern

  • Promoter Group

    0.20%

  • Public Share Holding

    99.80%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 11,000 0.19 11,000 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 500 0.01 0 1
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 11,500 0.20 11,000 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 941,143 15.98 941,143 24
Clearing Members 200,167 3.40 200,167 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 86,520 1.47 86,520 108
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 93,090 1.58 93,090 22
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,725,321 29.29 1,725,321 23
Individuals holding nominal share capital up to Rs. 1 lakh 2,832,059 48.08 2,832,059 7,350
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 200 0.00 200 1
Others 0 0.00 0 0
Sub Total 5,878,500 99.80 5,878,500 7,529
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 5,890,000 100.00 5,889,500 7,532

Company Background

Bacil Pharma LtdPharmaceuticals - Indian - Bulk Drugs

  • Bacil Pharma Ltd
  • BSE Code : 3688.0
  • ISIN : INE711D01018

  • Incorporation Year

    1987

  • Registered Office

    G2 & G3 Samarpan Complex
    chakala Andheri East, Mumbai,
    Maharashtra-400099

  • Telephone

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    Bhavana Tak

  • Auditor

    Laxmikant Kabra & Co LLP

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Bigshare Services Pvt Ltd
    E-2/3 Ansa Indl Est,
    Saki Vihar Road ,Sakinaka Andheri(E)
    Mumbai - Mumbai - 400072

Bacil Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Bacil Pharma 37.58 0.13 0.00 134.21 0.00
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10